£500 special discount for Drug Discovery conference in 4 weeks’ time

Drug-resistant diseases are one of the biggest threats to global health. They kill around 700,000 people a year, and new treatments are urgently needed [bbc news].

Attend Drug Discovery conference in 3 weeks’ time, where attendees can discuss ways of improving discovery cycles in chemistry and learn how to achieve a higher rate of technical success by implementation of new technologies.

With carefully selected experts, the two-day event will provide delegates with the most up to date content on the use of Artificial Intelligence in in silico drug discovery, CRISPR and PROTAC’s, as well as discussing advancements in medicinal chemistry, translational medicine and 3D structure based-discovery.

Snapshot of the Latest Attendees –  AbbVie, AstraZeneca, Aurelia Bioscience, Bayer AG, BenevolentAI, Epizyme, ETH Zürich, Exscientia, GHPC, Goethe University, GSK, Lundbeck, Japan Tobacco, JSC R-PHARM, MD Biosciences Inc, MedImmune, National Institute Of Advanced Industrial Science And Technology, Novartis Pharmaceuticals, Roche Pharmaceuticals, Sanofi-Aventis, Selcia Ltd, Sygnature Discovery, Technology Networks, ThermoFisher, TissUse, UCB BioPharma SPRL, UCB-Celltech, Vernalis Research Ltd and many more.

Visit the download centre on the event website to find presentations from last year’s Drug Discovery, past attendee lists, preliminary attendee lists, workshop details, PLUS interviews from AbbVie and TissUse.

There is currently an exclusive £500 manager special discount to take advantage of. There is limited availability, prospective attendees are advised to book now to avoid disappointment.

Alongside the two-day conference, there will be two pre-conference workshops taking place on Tuesday 20th March 2018. The morning session will be led by Nicolas Clare, Technical Project Leader at Axol Bioscience. He will discuss Induced Pluripotent Stem Cell Derived Models and their use in Drug Discovery. The afternoon workshop will be led by Emanuela Cuomo, Associate Principal Scientist at AstraZeneca who will provide an overview of CRISPR/Cas technologies and how they are applied to drug development.

For more details about the conference and registration information, visit www.drug-discovery.co.uk/pharmajourn

Drug Discovery
21st – 22nd March 2018
Copthorne Tara Hotel, London, UK
www.drug-discovery.co.uk/pharmajourn   

Contact Information:

For sponsorship and exhibition queries please contact Alia Malick at amalick@smi-online.co.uk. For delegate queries please contact Kieran Ronaldson at kronaldson@smi-online.co.uk. For media queries please contact Natasha Boumediene at nboumediene@smi-online.co.uk.

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk